Evaluation of genotoxic risk of handling cytostatic drugs in clinical pharmacy practice
- 25 Downloads
The genotoxic risk of handling antineoplastic drugs was evaluated in fifteen women preparing chemotherapeutics in the Pharmacy Department of the University Hospital Maastricht. Twenty nurses of the same hospital, who were not exposed to cytostatics, acted as controls. Endogenous exposure to antineoplastic drugs was assessed by determination of urine mutagenicity, as well as by analysis of urinary methotrexate levels. As genotoxicological end-points, sister chromatid exchanges and hypoxanthine guanine phosphoribosyl transferase locus point mutations were studied in peripheral lymphocytes obtained via venous puncture. No differences in urine mutagenic activity, in sister chromatid exchange frequencies and in hypoxanthine guanine phosphoribosyl transferase point mutation frequencies between exposed and non-exposed groups were detected. Higher sister chromatid exchange frequency was observed in smokers as compared to non-smokers.
KeywordsAntineoplastic agents Hypoxanthine guanine phosphoribosyl transferase Mutagenicity tests Pharmacies, hospital Urine
Unable to display preview. Download preview PDF.
- 1.Anonymous. Monographs on the evaluation of the carcinogenic risk of chemicals to human; chemicals, industrial processes and industries associated with cancer in humans. IARC Monogr 1982;1(Suppl 4).Google Scholar
- 8.Pesce MA, Bodourian SH. Evaluation of a fluorescence polarization immunoassay procedure for quantitation of methotrexate. Ther Drag Monitor 1986;8:115–21.Google Scholar
- 13.Kilbey BJ, Legator M, Nichols W, Ramel C. Handbook of mutagenicity test procedures. Amsterdam: Elsevier, 1984.Google Scholar
- 23.Chrysostomou A, Morley AA, Seshadri R. Mutation frequency in nurses and pharmacists working with cytotoxic drugs. Aust NZ J Med 1984;14:831–4.Google Scholar